The QMN Weekly Bulletin

Intellipharmaceutics’ Manufacturing Facility Passes FDA cGMP and Pre-Approval Inspection

Nov. 18, 2011
Intellipharmaceutics International announced that its Toronto-based oral solid dosage forms manufacturing facility has completed a cGMP and pre-approval inspection process by the U.S. Food and Drug Administration and has been granted “acceptable” status under the Agency’s strict regulatory guidelines.